BR0114933A - Uso de uma alga marinha ascophyllum sp. ou um extrato desta, dose unitária de uma preparação oral, e, método profilático e/ou terapêutico de tratamento de placa e/ou cálculo em um indivìduo mamìfero em necessidade do mesmo - Google Patents

Uso de uma alga marinha ascophyllum sp. ou um extrato desta, dose unitária de uma preparação oral, e, método profilático e/ou terapêutico de tratamento de placa e/ou cálculo em um indivìduo mamìfero em necessidade do mesmo

Info

Publication number
BR0114933A
BR0114933A BR0114933-4A BRPI0114933A BR0114933A BR 0114933 A BR0114933 A BR 0114933A BR PI0114933 A BRPI0114933 A BR PI0114933A BR 0114933 A BR0114933 A BR 0114933A
Authority
BR
Brazil
Prior art keywords
calculus
oral preparation
plaque
prophylactic
extract
Prior art date
Application number
BR0114933-4A
Other languages
English (en)
Inventor
Sune Wikner
Original Assignee
Sdc Swedencare Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20281587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0114933(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sdc Swedencare Ab filed Critical Sdc Swedencare Ab
Publication of BR0114933A publication Critical patent/BR0114933A/pt
Publication of BRPI0114933B1 publication Critical patent/BRPI0114933B1/pt
Publication of BRPI0114933B8 publication Critical patent/BRPI0114933B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Birds (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Endoscopes (AREA)

Abstract

"USO DE UMA ALGA MARINHA ASCOPHYLLUM SP. OU UM EXTRATO DESTA, DOSE UNITáRIA DE UMA PREPARAçãO ORAL, E, MéTODO PROFILáTICO E/OU TERAPêUTICO DE TRATAMENTO DE PLACA E/OU CáLCULO EM UM INDIVìDUO MAMìFERO EM NECESSIDADE DO MESMO". Uma preparação oral para a redução em mamíferos, por exemplo, ser humano, gato ou cachorro, de placas e/ou cálculos, tais como placa bacteriana, placa arteriosclerótica, placa aterosclerótica, placa pleural, cálculo dentário, cálculo renal, cálculo biliar e cálculo prostático, contém uma alga marinha Ascophyllum sp., especialmente A. nodosum, ou um extrato desta. A preparação oral é adequada para uso no método profilático e/ou terapêutico de tratamento de placa e/ou cálculo em um indivíduo mamífero.
BR0114933-4 2000-10-27 2001-09-27 uso de uma alga marinha ascophyllum nodosum ou um extrato desta para redução de placa e/ou cálculo em um indivíduo mamífero BRPI0114933B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003907-3 2000-10-27
SE0003907A SE0003907D0 (sv) 2000-10-27 2000-10-27 Komposition för eliminering av tandsten ur munnen
PCT/SE2001/002083 WO2002034279A1 (en) 2000-10-27 2001-09-27 Oral preparation containing seaweed for reduction of plaque and calculus

Publications (3)

Publication Number Publication Date
BR0114933A true BR0114933A (pt) 2004-01-06
BRPI0114933B1 BRPI0114933B1 (pt) 2018-05-29
BRPI0114933B8 BRPI0114933B8 (pt) 2021-05-25

Family

ID=20281587

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114933-4 BRPI0114933B8 (pt) 2000-10-27 2001-09-27 uso de uma alga marinha ascophyllum nodosum ou um extrato desta para redução de placa e/ou cálculo em um indivíduo mamífero

Country Status (22)

Country Link
US (1) US7125555B2 (pt)
EP (1) EP1328285B1 (pt)
JP (1) JP4648611B2 (pt)
KR (1) KR100890723B1 (pt)
CN (1) CN1230195C (pt)
AT (1) ATE319463T1 (pt)
AU (1) AU2001290473A1 (pt)
BR (1) BRPI0114933B8 (pt)
CA (1) CA2426936C (pt)
CY (1) CY1105379T1 (pt)
DE (1) DE60117824T2 (pt)
DK (1) DK1328285T3 (pt)
ES (1) ES2260286T3 (pt)
IS (1) IS2288B (pt)
MX (1) MXPA03003699A (pt)
NO (1) NO329352B1 (pt)
NZ (1) NZ525418A (pt)
PT (1) PT1328285E (pt)
RU (1) RU2275218C2 (pt)
SE (1) SE0003907D0 (pt)
SK (1) SK287572B6 (pt)
WO (1) WO2002034279A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001098335A2 (en) * 2000-06-20 2001-12-27 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
US6932980B1 (en) * 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
US20050267091A1 (en) * 2004-05-25 2005-12-01 Roger Berlin Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses
DE102004043945A1 (de) * 2004-09-11 2006-03-30 Henkel Kgaa Mund-, Zahn- und Zahnprotesenpflegemittel enthaltend die Plaquebildung inhibierende Substanzen
EA011286B1 (ru) * 2007-08-29 2009-02-27 Общество С Ограниченной Ответственностью "Вдс" Таблетка для профилактики и лечения заболеваний зубов и пародонта
FR2931071B1 (fr) * 2008-05-14 2010-08-13 Roquette Freres Confiserie aux algues pour la prevention des infections buccodentaires
US20100183523A1 (en) * 2009-01-22 2010-07-22 Wagner Richard E Dental composition and method
EP2210582B1 (en) * 2009-01-22 2019-09-18 Solarvest Bioenergy Inc. Dental composition comprising algae and method for producing thereof
FR2968558B1 (fr) 2010-12-14 2013-03-22 Ys Lab Composition a base d'extrait d'algues a usage bucco-dentaire
US8916179B2 (en) * 2011-10-25 2014-12-23 T.F.H. Publications, Inc. Ascophyllum nodosum animal chews
CN103877195A (zh) * 2013-11-15 2014-06-25 东南大学 一种用于治疗肾结石的中药配方组成及其服用方法
US20200305440A1 (en) * 2019-03-27 2020-10-01 UPL Corporation Limited Plant treatment composition and method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56117777A (en) * 1980-02-15 1981-09-16 Takanori Koshiro Diuretic health food
JPS56113269A (en) * 1980-02-15 1981-09-07 Takanori Koshiro Healthful food for promoting urination
FR2513122A1 (fr) * 1981-09-23 1983-03-25 Goemar Sa Nouveaux medicaments a base d'extraits d'algues, et formulations correspondantes
US4775525A (en) * 1985-12-16 1988-10-04 Ivo Pera Oral hygiene formulation containing sodium alginate
JP2691902B2 (ja) * 1988-01-19 1997-12-17 日本製粉株式会社 グルコシルトランスフェラーゼ阻害剤及びう蝕予防口腔用組成物
GB8803157D0 (en) 1988-02-11 1988-03-09 Nat Res Dev Denture protection
US4857331A (en) * 1988-03-31 1989-08-15 Warner-Lambert Company Sugarless pectin delivery system
JP3013060B2 (ja) * 1991-11-16 2000-02-28 株式会社ロッテ 虫歯菌歯牙付着阻害及び脱離のための口腔用組成物
DE4219360C2 (de) * 1992-06-12 1994-07-28 Milupa Ag Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren
US6255296B1 (en) * 1994-01-11 2001-07-03 Endomatrix, Inc. Composition and method for treating a patient susceptible to or suffering from a cardiovascular disorder or disease
GB2292146A (en) * 1994-08-11 1996-02-14 Merck & Co Inc HIV protease inhibitors useful for the treatment of AIDS
EP1007077B1 (en) * 1997-01-13 2009-10-07 Emory University Glutathione for the treatment of influenza infection
US6338856B1 (en) * 1998-02-27 2002-01-15 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
GB9819530D0 (en) * 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
JP4189620B2 (ja) * 2000-03-01 2008-12-03 ライオン株式会社 歯周疾患予防・治療用口腔用組成物

Also Published As

Publication number Publication date
CA2426936C (en) 2009-08-25
BRPI0114933B1 (pt) 2018-05-29
US20040022806A1 (en) 2004-02-05
EP1328285B1 (en) 2006-03-08
CA2426936A1 (en) 2002-05-02
DE60117824T2 (de) 2006-11-02
SK287572B6 (sk) 2011-03-04
RU2275218C2 (ru) 2006-04-27
CN1230195C (zh) 2005-12-07
NO329352B1 (no) 2010-10-04
JP4648611B2 (ja) 2011-03-09
PT1328285E (pt) 2006-07-31
SE0003907D0 (sv) 2000-10-27
EP1328285A1 (en) 2003-07-23
KR20030048082A (ko) 2003-06-18
AU2001290473A1 (en) 2002-05-06
DE60117824D1 (de) 2006-05-04
IS6795A (is) 2003-04-23
BRPI0114933B8 (pt) 2021-05-25
SK5062003A3 (en) 2003-08-05
WO2002034279A1 (en) 2002-05-02
DK1328285T3 (da) 2006-07-17
ES2260286T3 (es) 2006-11-01
MXPA03003699A (es) 2003-08-07
JP2004512309A (ja) 2004-04-22
KR100890723B1 (ko) 2009-03-26
IS2288B (is) 2007-10-15
CN1471403A (zh) 2004-01-28
US7125555B2 (en) 2006-10-24
ATE319463T1 (de) 2006-03-15
CY1105379T1 (el) 2010-04-28
NO20031808D0 (no) 2003-04-23
NZ525418A (en) 2004-11-26
NO20031808L (no) 2003-04-23

Similar Documents

Publication Publication Date Title
BR0114933A (pt) Uso de uma alga marinha ascophyllum sp. ou um extrato desta, dose unitária de uma preparação oral, e, método profilático e/ou terapêutico de tratamento de placa e/ou cálculo em um indivìduo mamìfero em necessidade do mesmo
BR0110420A (pt) Agonistas muscarìnicos
BR0312749A (pt) Barra de toalete, método para esfoliar e umedecer simultaneamente a pele e método para conferir ao usuário um nìvel variável de esfoliação e umedecimento em regiões diferentes do corpo
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
ATE123936T1 (de) Mittel mit physiologischem kühleffekt und für diese mittel geeignete wirksame verbindungen.
BR0113447A (pt) Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica
BR9815255A (pt) Toxina de botulismo modificada, vacina oralcontra o botulismo, vacina oral contra umantìgeno selecionado e método para ministraroralmente um agente terapêutico a um animal
BR0112685A (pt) Composição nutricional
BR0111207A (pt) Combinações de um antagonista receptor de endotelina e um composto antiepiléptico tendo propriedades de alìvio da dor ou analgésicos
BR0212142A (pt) Método e sistema para tratamento de acne
BR0111196A (pt) Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
DE59912182D1 (de) Vorrichtung zur behandlung von körpergewebe, insbesondere von oberflächennahem weichgewebe, mittels ultraschall
HU9700056D0 (en) New pharmaceutical composition for treating pains
BR0205722A (pt) Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor
BR0015478A (pt) Métodos de diminuição do volume de uma célula, de tratamento de pessoa e de inflamação, de dessensibilização de dente e de redução de dor em úlceras, composição terapêutica, cimento dentário, goma de mascar ou bala e composições dentárias e de branquamento dentário
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
BR0114392A (pt) Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv
AU5029599A (en) Methods for eradication of nanobacteria
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
BRPI0406796A (pt) Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina
BR0010669A (pt) Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina
BR0304197A (pt) Composições para esfoliação da pele e tratamento de cravos
BR0101486A (pt) Composições farmacêuticas de uso tópico, aplicadas no tratamento de lesões de pele e/ou mucosas; uso das composições no tratamento de lesões de pele e/ou mucosas e uso de compostos no tratamento de lesões de pele e/ou mucosas
Krorner The case for ostectomy--a time-tested therapeutic modality in selected periodontitis sites.
HUP9900007A2 (hu) Készítmény baromfialom kezelésére

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: SDC SWEDENCARE AB (SE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 36/03 (2006.01), A61K 8/9711 (2017.01), A61P

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25D Requested change of name of applicant approved
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/05/2018, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/09/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2689 DE 19/07/2022 POR TER SIDO INDEVIDA. UMA VEZ QUE A VIGENCIA TERMINAVA EM 27/07/2021.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 27/09/2021